
Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their platform offers a community-driven approach, allowing users to fine-tune and integrate these models into their workflows, thereby enhancing research capabilities in the biological sciences. With a commitment to accessibility and collaboration, Helical positions itself as a key player in the AI for bio sector, catering to researchers and developers looking for innovative solutions.

Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their platform offers a community-driven approach, allowing users to fine-tune and integrate these models into their workflows, thereby enhancing research capabilities in the biological sciences. With a commitment to accessibility and collaboration, Helical positions itself as a key player in the AI for bio sector, catering to researchers and developers looking for innovative solutions.
What they do: Platform for Bio Foundation Models enabling in-silico experiments for drug discovery and R&D
HQ: Luxembourg
Stage / funding: Seed (closed Jun 28, 2024)
Founders: Mathieu Klop; Maxime Allard; Rick Schneider
| Company |
|---|
Drug discovery and pharmaceutical R&D using AI-driven in-silico experiments
2024
Biotechnology Research
Reported seed round with seven investors
“Has participation from early-stage investors and angel/backer set including Frst and named investors”
Helical is powering the in-silico labs for biology. Drug discovery still runs in wet labs: slow, expensive, and locked in physical trial-and-error.
We’re changing that. Our platform makes Bio Foundation Models directly usable for discovery, enabling pharma teams to run millions of virtual experiments in days, not years.
That means you have a rare opportunity to help define how the next generation of drugs will be discovered. Today, leading pharma companies across the globe already use Helical. And we’re just getting started.
We’re a talent-dense team building a generation-defining company from Europe. We seek people who care deeply, ship fast, and want their work to change how medicine is made.
Join us on this journey as part of our founding team, you’ll help shape the in-silico labs of tomorrow.
As an Operations & Strategy Intern, you’ll work directly with the founding team to help design, scale, and operate the core of the company. This isn’t a typical internship, you’ll be trusted with high-impact projects from day one.
You’ll work across teams, and be exposed to every part of the business. If you’re excited by the idea of helping build a company from the ground up, this is your chance.
This internship is designed to be fast-paced, high-learning, and high-ownership, with a clear path to full-time if there’s a mutual fit.
You’ll take ownership across:
You should apply if:
You’ll stand out if:
You’ve been in early-stage, high-responsibility environments (startups, research labs, student orgs)
You’re available full-time for 4–6 months in London or Luxembourg
You’re a student or recent graduate in:
Life sciences/computational biology/bioinformatics/AI, with a desire to gain experience in business and operations
Or business, economics, or general engineering, with a demonstrated interest in biotech or AI (courses, internships, side projects, writing)
You’re highly tool-savvy, you've used Notion, Sheets, Airtable, or automation tools to solve real problems
You write clearly and structure your thoughts well, whether in a document, presentation, or LinkedIn post
You take ownership naturally, you spot a problem, suggest a fix, and drive it forward